Pricing Log in Create free account
Saturday 17 October 2026 Export MRNA’s income statement to Excel — free account

Moderna, Inc.

MRNA Healthcare Biotechnology

Moderna, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, down 39.9% from fiscal 2024. In the quarter to June 2026, revenue grew 2.11%, EPS grew 7.51%, free cash flow grew 38.9% and total debt rose 1,765.6%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100.

218.01 18.49 −7.82%
Market cap
$94.4B
P/E
0.0×
Fwd P/E
−5.5×
Dividend yield
—
F-score
3/9
Altman Z
2.46
Beneish M
−3.52
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Moderna, Inc. (MRNA) P/B ratio

Alert me on P/B ratio

As of 16 October 2026, Moderna, Inc. (MRNA) trades at a P/B ratio of 12.8×. Over the past ten years it has ranged from 0.0× (December 2018) to 29.1× (August 2021); the current reading is higher than 86% of that period. That is above the Biotechnology industry median of 2.1× and above the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2025 1.3× (9.46%)
FY2024 1.5× (52.78%)
FY2023 3.1× (15.88%)
FY2022 3.7× (49.04%)
FY2021 7.2× (53.44%)
FY2020 15.5× 182.02%
FY2019 5.5× 580.87%
FY2018 0.8× —
FY2017 0.0× —
FY2016 0.0× —

Quarterly newest first

Period P/B ratio Change
Jun 2026 4.1× 52.19%
Mar 2026 2.7× 104.25%
Dec 2025 1.3× 22.83%
Sep 2025 1.1× (5.20%)
30 more quarters

Against its own ten years

Low 0.0× High 29.1×
Ten-year median 3.4×
Current reading's percentile 86

P/B ratio against peers

Company P/B ratio
REGN Regeneron Pharmaceuticals, Inc. compare 2.6×
RPRX Royalty Pharma PLC compare 2.8×
ROIV Roivant Sciences Ltd. compare 4.9×
ARGX argenex SE compare 6.1×
VRTX Vertex Pharmaceuticals Incorporated compare 6.3×
ONC BeOne Medicines Ltd. - Sponsored ADR compare 8.0×
MRNA Moderna, Inc. 12.8×
RVMD Revolution Medicines, Inc. compare 14.4×
ALNY Alnylam Pharmaceuticals, Inc. compare 22.9×
Biotechnology industry median 2.1×
Healthcare sector median 2.3×
Market median 1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on MRNA